Home/Rab Diagnostics/Anette Weyergang
AW

Anette Weyergang

CEO

Rab Diagnostics

Therapeutic Areas

Rab Diagnostics Pipeline

DrugIndicationPhase
Rab-GTPase Biomarker Platform DevelopmentOncology (ADC therapies)Pre-clinical